Photo of Bexis

Almost from the day this blog was founded, we’ve been arguing that class actions have no place in prescription medical product liability litigation. We’ve put up several posts containing lists of cases to that effect – but none of them were complete (or purported to be).
One of the things that we’ve often thought about

First the Digitek MDL gave us a new weapon – the “Digitek Order” – to ensure plaintiffs’ counsel comply with their Rule 11 obligations to actually investigate their clients’ claims before filing thousands of cases. Novel concept, right? And now we have another helpful opinion – a new decision out of the MDL

Those pesky state AGs, usually aided by the plaintiffs’ bar, are an increasingly important player in coordinated drug and device litigation. And there always seems to be something vaguely unfair about a state filing a parens patriae action in its backyard state court, and then waving the (state) flag about how the AG is simply

Photo of Bexis

We just got word that certification of the world’s largest class action, Dukes v. WalMart, slip op. (9th Cir. April 26, 2010) (en banc), was affirmed in large part in a 137-page whopper of a decision.
The court describes its action as follows:

We affirm the district court’s certification of a Federal Rule of

It’s not a drug or device case, but a recent per curiam from the 7th Circuit (with a panel that includes McConnell’s BFF Posner) recently caught our eye. American Honda Motor Co., Inc. v. Allen, __ F.3d __, 2010 WL 1332781 (7th Cir. Apr. 7, 2010), may turn out to be handy for anyone

Good luck bringing a class action in New Jersey federal court invoking the “off-label marketing” bugaboo. Last year, we had Schering-Plough Corp. v. Intron/Temodar Consumer Class Action, a putative class action we’ve previously covered. In that case, the court dismissed a third-party payor (TPP) class action for failure to state a claim where

Photo of Bexis

We’ve previously argued that courts should eliminate class action tolling of the statute of limitations in the mass tort context. In a nutshell, we see the rule first announced in American Pipe & Construction Co. v. Utah, 414 U.S. 538 (1974) – allowing for tolling of the statute of limitations for all members of

It’s March Madness time, and the language of basketball fills the air. One expression that has moved from the basketball courts to everyday language is “no harm, no foul.” “No harm, no foul” (in tougher games, no blood, no foul) is the response to a claim that a foul should be called for